no more compounding semaglutide Despite FDA ruling, compounded GLP-1s

Get in the habit of walking, try a new exercise class you find interesting, or pick up biking to stay on top of your physical activity

Fats provide satiety, are calorie-dense, and are helpful for weight balance

doi: 10.1038/s41586-018-0255-3 47 EvensethLSMGabrielsenMSylteI

Semaglutide is a GLP-1 agonist and works by increasing insulin release, lowering the amount of glucagon released, delaying gastric emptying, and reducing appetite

While semaglutide activates GLP-1 receptors, and tirzepatide activates both GIP and GLP-1 receptors, retatrutide also activates a third glucagon

This trial was registered with the Thai Clinical Trials Registry (TCTR20221219003)